Overview
You can access the company’s website by clicking here.
News
-
16 Aug 2018 2 min read
WPCT avoids losses on Woodford backed Abzena
WPCT avoids losses on Woodford-backed Abzena Woodford Investment Management will have to take a second painful hit on one of its major biotech investments in less than a week, after the UK-based drug discovery services company Abzena agreed to a low-ball private equity takeout today after seeing a sustained share price decline. This deal follows the […]
-
10 Aug 2018 1 min read
Woodford finally closes chapter on failed Vernalis investment
Woodford finally closes chapter on failed Vernalis investment Neil Woodford’s eponymous Patient Capital Trust (WPCT) will have to look forward to receiving just £1.8m for the 30.6m shareholding – acquired in 2015 for £18.5m – in Vernalis, the UK biotech whose failed endeavour to break into the US cough/cold market led to it being put up […]
